A Phase Ib/II Study of the BRAF Inhibitor Encorafenib Plus the MEK Inhibitor Binimetinib in Patients with BRAFV600E/K-mutant Solid Tumors
暂无分享,去创建一个
R. Sullivan | P. Ascierto | R. Dummer | S. Patel | D. Tan | C. Lebbé | M. Carlino | S. Siena | J. Weber | L. Wollenberg | M. Pickard | V. Sandor | E. Élez | Lance A. Wollenberg